IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,210,809 | -25.3% | 312,347 | -13.7% | 0.01% | -14.3% |
| Q2 2023 | $21,703,301 | +20.1% | 361,963 | -1.0% | 0.01% | +16.7% |
| Q1 2023 | $18,074,374 | -13.5% | 365,582 | -0.1% | 0.01% | -14.3% |
| Q4 2022 | $20,883,853 | +22.0% | 365,934 | +0.3% | 0.01% | +16.7% |
| Q3 2022 | $17,121,000 | +35.0% | 364,738 | +7.3% | 0.01% | +50.0% |
| Q2 2022 | $12,683,000 | +23.9% | 339,942 | -0.7% | 0.00% | +33.3% |
| Q1 2022 | $10,240,000 | -10.2% | 342,478 | +2.8% | 0.00% | 0.0% |
| Q4 2021 | $11,405,000 | -8.3% | 333,080 | -0.7% | 0.00% | -25.0% |
| Q3 2021 | $12,437,000 | +227.5% | 335,512 | +245.1% | 0.00% | +300.0% |
| Q2 2021 | $3,797,000 | -8.5% | 97,226 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $4,151,000 | – | 97,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |